Health
Beckman Coulter Launches Semi-Quantitative Access SARS-CoV-2 IgG II Antibody Test – HospiMedica
Beckman Coulter Diagnostics (Brea, CA, USA) has launched its Access SARS-CoV-2 IgG II assay that measures a patient’s relative level of antibodies in response to…
Beckman Coulter Diagnostics (Brea, CA, USA) has launched its Access SARS-CoV-2 IgG II assay that measures a patients relative level of antibodies in response to a previous SARS-CoV-2 infection. The assays new capabilities enable clinicians to establish a baseline to evaluate an individuals immune response to the SARS-CoV-2 virus based on a numerical value and assess relative changes of an individuals immune response to the virus over time. The assay may also help researchers as they begin to understand…
-
Business21 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
General21 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
General21 hours agoTaiwan’s President Lai Ching-te calls for peace and dialogue with China while also calling for defence boosts
-
Noosa News7 hours agoCommissioner thanks police officer who threw a speed radar at a car